Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1877868Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pathology
- CHEMISTRY
NIH Funding · FY2025
Linked Award Amount
$1.2M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#14,255
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Cheng Zhu as a PI. Multi-PI records show the full award amount for context.
- 5R01CA284604-02R01Optimizing TCR-CD3 signaling for immunotherapy of cancer$634.2Kaward amount
- 5U01CA280984-03U01Dysregulated mechanoimmunology of epigenetics-driven lymphomas$518.1Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Cheng Zhu as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNYU Grossman School of Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2768
- 2024Entered Top 25% NationallyRanked #2768
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Cheng Zhu.